Published Technical Disclosure Archive

Synergistic Shield System for Enhanced Recurrent Laryngeal Nerve Protection

Publication ID: 24-11857696_0008_PTD
Published: October 28, 2025
Category:Synergistic Combinations

Legal Citation

pr1or.art Inc., “Synergistic Shield System for Enhanced Recurrent Laryngeal Nerve Protection,” Published Technical Disclosure No. 24-11857696_0008_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857696_0008_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,696.

Summary of the Inventive Concept

A novel system integrating a biologic tissue shield with advanced technologies such as MEMS, AI, IoT, and blockchain to provide real-time monitoring and protection of the recurrent laryngeal nerve during neck surgeries.

Background and Problem Solved

The original patent addressed the need for protecting the recurrent laryngeal nerve during neck surgeries. However, the original shield design had limitations in terms of real-time monitoring and data tracking. The new inventive concept addresses these limitations by incorporating synergistic combinations of advanced technologies to provide enhanced protection and monitoring capabilities.

Detailed Description of the Inventive Concept

The Synergistic Shield System comprises a biologic tissue shield integrated with a micro-electro-mechanical system (MEMS) for real-time monitoring of the nerve's condition. The system also incorporates an AI-powered imaging system to track the nerve's condition and provide alerts to the surgeon. Additionally, the system includes a neural network-based predictive model to forecast potential nerve damage. The shield is designed to be personalized using 3D printing and IoT sensors for real-time monitoring. A blockchain-based system ensures secure tracking and verification of shield usage.

Novelty and Inventive Step

The new inventive concept's novelty lies in the synergistic integration of advanced technologies such as MEMS, AI, IoT, and blockchain with the biologic tissue shield, providing a comprehensive system for enhanced recurrent laryngeal nerve protection. The inventive step is the combination of these technologies to provide real-time monitoring, predictive modeling, and secure tracking capabilities.

Alternative Embodiments and Variations

Alternative embodiments of the Synergistic Shield System could include the use of different biologic tissue materials, varying MEMS designs, or alternative AI-powered imaging systems. Variations could also include the integration of additional sensors or technologies to further enhance the system's monitoring and predictive capabilities.

Potential Commercial Applications and Market

The Synergistic Shield System has significant commercial potential in the medical device industry, particularly in the field of neck surgeries. The system's enhanced protection and monitoring capabilities could reduce the risk of nerve damage, improving patient outcomes and reducing healthcare costs. The system's personalized 3D printing and IoT sensor integration could also provide opportunities for partnerships with medical imaging and IoT companies.

CPC Classifications

SectionClassGroup
A A61 A61L27/3834
A A61 A61L27/54
A A61 A61L27/58
A A61 A61L2430/22
A A61 A61L2430/32

Field of Art

Medical device technologies for surgical nerve protection, specifically focusing on biologic tissue shields and minimally invasive surgical interventions, with expertise in biomedical engineering, surgical technologies, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with advanced degrees, experience in surgical technologies, familiarity with medical imaging, sensor integration, and advanced materials for surgical applications

Obviousness Rationale

A PHOSITA would recognize that integrating advanced monitoring technologies with the existing biologic tissue shield concept represents a predictable extension of the source patent's core protection method. The fundamental nerve protection mechanism remains consistent, with technological enhancements providing additional diagnostic and protective capabilities. The integration of MEMS, AI, and IoT represents standard engineering approaches to augmenting medical device functionality through sensor and computational technologies.

Obvious Combinations & Variations

Source Patent Element
Biologic tissue shield for protecting recurrent laryngeal nerve during neck surgery
PTD Variation
Adding MEMS-based real-time monitoring integrated directly into the biologic tissue shield
Obviousness Reasoning
Integrating sensors into medical protective devices is a known technique for enhancing diagnostic capabilities, representing a predictable application of existing technological approaches
Source Patent Element
Flexible biologic tissue that conforms to surrounding anatomical structures
PTD Variation
3D-printed personalized shields using patient-specific medical imaging data
Obviousness Reasoning
Customization of medical devices using patient imaging is a standard design approach that would be obvious to optimize protection and fit
Source Patent Element
Dissolvable or absorbable biologic tissue shield
PTD Variation
Adding blockchain tracking and IoT sensor integration for usage verification
Obviousness Reasoning
Implementing digital tracking for medical device usage represents a logical extension of existing medical device management technologies
Source Patent Element
Translucent or transparent biologic tissue shield
PTD Variation
AI-powered imaging system for continuous nerve condition monitoring
Obviousness Reasoning
Applying computational imaging technologies to medical diagnostics is a predictable evolution of existing medical monitoring techniques
Source Patent Element
Neck surgery nerve protection method
PTD Variation
Neural network-based predictive modeling for potential nerve damage
Obviousness Reasoning
Using machine learning for medical risk prediction is a standard approach in developing advanced diagnostic technologies
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857696 and the disclosed technological variations, a person having ordinary skill in the art would find the proposed Synergistic Shield System obvious as a predictable combination of known medical device technologies. The fundamental nerve protection method remains substantially unchanged, with technological enhancements representing standard engineering approaches to augmenting medical device functionality through sensor integration, computational analysis, and personalized design approaches.

Original Patent Information

Patent NumberUS 11,857,696
TitleShield for recurrent laryngeal nerve and associated methods